Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (51-60 of 391) with videos related to

Pageof 40
Sort By:
Annals of Neurology|December 11, 2012
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controlsThomas J Esparza, Hanzhi Zhao, John R Cirrito, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2026
Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform TrialYan Li, Guoqiao Wang, Chengjie Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2014
Continuous 24-hour leptin, proopiomelanocortin, and amino acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and amino acid levelsSharon L Wardlaw, Charles F Burant, Samuel Klein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populationsGuoqiao Wang, Yan Li, Eric McDade, et al.
Alzheimer'S Research & Therapy|October 18, 2013
Dominantly Inherited Alzheimer Network: facilitating research and clinical trialsKrista L Moulder, B Joy Snider, Susan L Mills, et al.
Plos One|March 21, 2014
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous systemJustyna A Dobrowolska, Tom Kasten, Yafei Huang, et al.
Alzheimer'S Research & Therapy|October 9, 2020
Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adultsLingxiao He, Philipe de Souto Barreto, Geetika Aggarwal, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 13, 2026
Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathologySatya V V N Kothapalli, Tammie L S Benzinger, Randall J Bateman, et al.
Alzheimer'S Research & Therapy|July 24, 2015
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's diseaseJoshua D Grill, Randall J Bateman, Virginia Buckles, et al.
Statistics in Medicine|May 16, 2018
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong, et al.
Pageof 40

Showing results (51-60 of 391) with videos related to

Sort By:
Pageof 40
Annals of Neurology|December 11, 2012
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controlsThomas J Esparza, Hanzhi Zhao, John R Cirrito, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2026
Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform TrialYan Li, Guoqiao Wang, Chengjie Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2014
Continuous 24-hour leptin, proopiomelanocortin, and amino acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and amino acid levelsSharon L Wardlaw, Charles F Burant, Samuel Klein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populationsGuoqiao Wang, Yan Li, Eric McDade, et al.
Alzheimer'S Research & Therapy|October 18, 2013
Dominantly Inherited Alzheimer Network: facilitating research and clinical trialsKrista L Moulder, B Joy Snider, Susan L Mills, et al.
Plos One|March 21, 2014
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous systemJustyna A Dobrowolska, Tom Kasten, Yafei Huang, et al.
Alzheimer'S Research & Therapy|October 9, 2020
Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adultsLingxiao He, Philipe de Souto Barreto, Geetika Aggarwal, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 13, 2026
Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathologySatya V V N Kothapalli, Tammie L S Benzinger, Randall J Bateman, et al.
Alzheimer'S Research & Therapy|July 24, 2015
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's diseaseJoshua D Grill, Randall J Bateman, Virginia Buckles, et al.
Statistics in Medicine|May 16, 2018
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong, et al.
Pageof 40